Human retroviruses and demyelinating diseases

Area of Science:

• Neurology
• Virology
• Immunology

Background:

• Human retroviral infections, including Human T-lymphotropic virus (HTLV) and Human Immunodeficiency Virus (HIV), significantly impact medical and scientific fields.
• The nervous system is a primary target organ for these retroviruses, leading to diverse neurological syndromes affecting the brain, spinal cord, nerves, and muscles.

Purpose of the Study:

• To highlight the neurological manifestations of HTLV and HIV infections.
• To emphasize the importance of considering retroviral causes in patients presenting with neurological disorders that mimic other conditions like Multiple Sclerosis (MS).
• To inform clinicians about the diagnostic approach for retroviral-associated neurological diseases.

Main Methods:

• Review of clinical, laboratory, neurophysiological, and neuroimaging features of retroviral-associated neurological diseases.
• Discussion of the molecular mechanisms underlying retroviral neurotoxicity and host immune responses.
• Emphasis on systematic patient evaluation and diagnostic testing.

Main Results:

• Neurological syndromes associated with HTLV-I/II (HAM/TSP) and HIV (encephalomyelitis) can closely resemble MS.
• Retroviral infections are prevalent and can present with varied neurological symptoms.
• Diagnostic suspicion and testing for HIV and HTLV are recommended for unexplained neurological disorders.

Conclusions:

• Clinicians should maintain a low threshold for testing HIV and HTLV in patients with neurological disorders due to the potential for misdiagnosis and the prevalence of these infections.
• The pathogenesis of retroviral-associated neurological diseases involves complex interactions between viral components, host immune responses, and cellular gene expression.
• Early and accurate diagnosis of retroviral infections is critical for managing associated neurological complications.